Oral iron chelation is here.
- 23 November 1991
- Vol. 303 (6813) , 1279-1280
- https://doi.org/10.1136/bmj.303.6813.1279
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Design, Properties, and Effective Use of the Oral Chelator L1 and OtherAnnals of the New York Academy of Sciences, 1990
- L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia majorBritish Journal of Haematology, 1990
- Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patientsThe Lancet, 1990
- Long‐term trial with the oral iron chelator 1,2‐dimethy1‐3‐hydroxypyrid‐4‐one (L1) II. CLINICAL OBSERVATIONSBritish Journal of Haematology, 1990
- Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) I. IRON CHELATION AND METABOLIC STUDIESBritish Journal of Haematology, 1990
- Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-oneClinical Pharmacology & Therapeutics, 1990
- Oral iron chelation with L1The Lancet, 1990
- Drug Metabolism by Leukocytes and Its Role in Drug-Induced Lupus and Other Idiosyncratic Drug ReactionsCritical Reviews in Toxicology, 1990
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- The law and Lewis Carroll.1986